Enabling Meaningful Metabolic Disease Research

Clear efficacy signals are as crucial as keeping research representative and reasonable in this complex field. Worldwide delivers studies that make sense for everyone.

Learn More

Leveraging our metabolic expertise

Whether your indication has millions of potential participants across the globe or just dozens, know that Worldwide’s dedicated team and global network of trusted partner sites can offer the expertise you need to succeed. Our extensive group of subject matter experts in both rare and common metabolic conditions help get studies done right.

Scott Beasley

Executive Director, Project Management, MASH

Scott’s experience includes project management, clinical team management, portfolio development, and training across all phases of development, including compassionate use programs. He has more than 24 years of experience in the industry, with extensive MASH/MASLD experience in Phase II and several Phase III programs. His proven leadership and strategic protocol and operational expertise ensure successful implementation and delivery for his projects.

Meet Scott

Monika Iten, PhD

Vice President Project Management, Cardiovascular

Rafal Ziecina, MD, PhD

Executive Director, Scientific Solutions, Cardiovascular, Endocrine & Metabolic

Lucy Bennett

Executive Director, Project Management

Attila Timar-Peregrin, MD, PhD

Executive Director, Medical Affairs & Therapeutic Area Lead, Digestive Diseases

MarieElena Cordisco

Senior Director Therapeutic Strategy Lead Metabolic

Our experts help bring clarity to complexity.

Get in touch

At Worldwide, we understand that our greatest strength is our personnel—our expert teams around the world that craft unparalleled design and logistics solutions for even the most challenging studies. When you start with a better CRO team, you get a better study experience for the life of your program.

Broad and deep project team experience

Worldwide offers broad individual and combined team experience across multiple metabolic indications. No matter the size of your study, you get a dedicated, experienced team.

Core imaging labs and central laboratory services

Worldwide is dedicated to maximizing clinical information while minimizing patient discomfort and safety concerns. That’s why our central, bioanalytical, core imaging, and ECG laboratories offer PK/PD and biomarker tests, whole organ volume analysis (liver and spleen), hepatic fat fraction (MRI-PDFF), liver stiffness (MR elastography), SAT/VAT fat depot segmentation, and vibration controlled transient elastography (VCTE) +/- controlled attenuation parameter (CAP).

Robust site and KOL relationships

Worldwide has a large and growing global network of leading investigators, consultants, key opinion leaders, and medical experts in the fields of endocrinology and metabolic health.

Support from early phase through late phase

Worldwide offers full-service support to metabolic studies from Phase I, starting with our co-located Clinical Pharmacology Unit and Bioanalytical lab, through post-marketing approval.

Metabolic Experience

Common Disorders

Chronic Kidney Disease
Diabetes Type 1/Juvenile
Diabetes Type 2
Dyslipidemia
Kidney Disease
Metabolic dysfunction-associated steatotic liver disease (MASLD)
Metabolic dysfunction-associated steatohepatitis (MASH)
Obesity

Rare Endocrine and Metabolic Disorders

Adrenal Insufficiency
Congenital Adrenal Hyperplasia
Fabry Disease
Familial Chylomicronemia Syndrome
Fatty Acid Biosynthesis Disorders
Growth Hormone Deficiency
Homozygous Familial Hypercholesterolemia
Lysosomal Storage Disorder
Mucopolysaccharidosis
Niemann-Pick Disease
Phenylketonuria
Tyrosinemia

Learn More – Rare Disease

Meet our team at the following conferences

May 18-21, Washington DC

May 15-16, Philadelphia

June 1-4, Boston

June 5-8, Milan

June 21-24, Orlando

November 15-19, San Diego